SOX17 and esophageal squamous cell carcinoma: Moreover, the promoter hypermethylation of SOX17 correlates with poor chemoradiation therapy response in ESCC and SOX17 overexpression sensitizes the response through the downregulation of DNA repair genes or damage response genes [41].